What Wegovy Does in Your Body

Wegovy is a weekly injection containing semaglutide, a compound that mimics a hormone your gut naturally produces called GLP-1. When you eat, your intestines release GLP-1 to signal fullness to your brain and slow how fast your stomach empties. Wegovy amplifies this signal, which is why people using it typically feel satisfied with smaller portions and think about food less often.

The mechanism is straightforward: semaglutide binds to GLP-1 receptors in your brain's appetite centers and in your digestive tract. This dual action reduces hunger signals and increases the time food stays in your stomach, creating a sustained sense of fullness. It does not speed up your metabolism or burn calories directly — it changes how much you want to eat.

Wegovy was approved by the FDA in 2021 for chronic weight management in adults with obesity or overweight plus at least one weight-related health condition. The same active ingredient, at a lower dose, is sold as Ozempic for type 2 diabetes management, though Ozempic is not approved for weight loss alone.

Key Takeaways

  • Wegovy reduces appetite and slows stomach emptying by mimicking GLP-1, a natural hormone, so weight loss comes from eating less rather than burning more calories.
  • Clinical trials show people lose 15 to 22 percent of their starting body weight over 68 weeks when using Wegovy alongside diet and exercise, compared to 2 to 3 percent with placebo.
  • Common side effects include nausea, vomiting, and constipation, especially when doses increase, and these often fade after a few weeks at each dose level.
  • Weight typically returns within one to two years after stopping Wegovy if diet and exercise habits do not change, because the compound itself is not permanent.
  • Wegovy costs $900 to $1,300 per month without insurance, and coverage varies widely by plan and state.

What the Clinical Trials Actually Found

The evidence for Wegovy comes from the STEP trials, a series of randomized controlled studies in which some participants received Wegovy injections and others received placebo, all while following a reduced-calorie diet and exercise plan. These are the gold standard in medical research because they control for placebo effect and lifestyle changes alone.

In STEP 1, the largest trial, participants using Wegovy lost an average of 15 percent of their body weight over 68 weeks. The placebo group lost 2.4 percent. In STEP 3, which included people with type 2 diabetes, the Wegovy group lost 17 percent while placebo lost 3 percent. STEP 4 followed people for a year after they stopped the medication: those who stayed on Wegovy continued losing weight, while those switched to placebo regained most of what they had lost.

These numbers matter because they show Wegovy works, but they also show it works within a specific context — all participants were told to eat fewer calories and move more. The trials do not answer whether Wegovy alone, without diet changes, produces weight loss. The weight loss also plateaus: most people reach their lowest weight around 68 weeks and then stabilize, rather than continuing to lose indefinitely.

Side Effects and What to Expect

Nausea is the most common side effect, occurring in roughly 25 to 40 percent of people depending on the dose. Vomiting, constipation, and diarrhea are also frequent, especially when the dose increases. Most people report that nausea peaks in the first week after a dose increase and then improves over the next two to three weeks as the body adjusts.

Serious side effects are rare but documented. There have been reports of pancreatitis (inflammation of the pancreas), gallbladder problems, and changes in blood sugar in people with diabetes. People with a personal or family history of medullary thyroid cancer or multiple endocrine neoplasia type 2 should not use semaglutide, because animal studies showed it increased thyroid tumors in rodents — though this has not been observed in humans.

Dehydration is a practical concern because nausea and vomiting can reduce fluid intake. Drinking water consistently and eating small, bland meals (crackers, broth, plain rice) during adjustment periods helps many people manage the transition to each new dose.

How Long Weight Loss Lasts After You Stop

Wegovy is not a permanent fix. STEP 4 showed that when people stopped the medication, they regained weight steadily over the following year. On average, people who switched from Wegovy to placebo regained about two-thirds of the weight they had lost, though individual results varied widely.

The reason is biological: Wegovy suppresses appetite while you are taking it, but it does not rewire your hunger signals permanently. Once the compound leaves your system (it has a half-life of about one week), your GLP-1 receptors return to baseline function. If your eating habits and activity level do not change, your appetite and weight tend to return to where they started.

This does not mean Wegovy is a failure — it means it is a tool that works while you use it. Some people use it to break the cycle of weight gain, establish new eating patterns, and then maintain those patterns after stopping. Others use it long-term, the way someone with high blood pressure uses a blood pressure medication. Both approaches are medically reasonable, depending on your goals and what your doctor recommends.

Cost and Insurance Coverage

Wegovy costs approximately $900 to $1,300 per month when paid out of pocket, though prices vary by pharmacy and region. A year of treatment runs $10,000 to $15,000 without insurance coverage.

Insurance coverage is inconsistent. Some plans cover Wegovy for people with obesity plus a weight-related condition like type 2 diabetes or heart disease. Others do not cover it at all, or cover it only after you have tried and failed other weight-loss approaches. Medicare does not cover Wegovy for weight loss, though it does cover Ozempic (the same compound at a lower dose) for diabetes. Medicaid coverage varies by state — some states cover it, others do not.

If your insurance does not cover Wegovy, some manufacturers offer patient information programs that reduce the cost based on income. Your doctor's office or pharmacist can help you find these programs and determine whether you meet the income thresholds.

Who Should and Should Not Use Wegovy

Wegovy is intended for adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher plus at least one weight-related condition such as type 2 diabetes, high blood pressure, or heart disease. It is not approved for people under 18 or for weight loss in people without these criteria.

You should not use Wegovy if you have a personal or family history of medullary thyroid cancer, multiple endocrine neoplasia type 2, or a severe allergic reaction to semaglutide. Pregnancy is a contraindication — semaglutide may harm a developing fetus, so you need to stop at least two months before trying to conceive. People with a history of pancreatitis, severe kidney disease, or certain eye conditions related to diabetes should discuss Wegovy carefully with their doctor.

Wegovy works best when combined with changes to diet and physical activity. If you are not willing or able to make those changes, the medication will still reduce appetite, but the weight loss will be smaller and may not be worth the cost and side effects.

Wegovy Versus Other Weight-Loss Approaches

Wegovy is one option among several. Older medications like phentermine (a stimulant) and orlistat (which blocks fat absorption) work through different mechanisms and have different side effect profiles. Tirzepatide, a newer compound that acts on both GLP-1 and another appetite hormone called GIP, shows slightly larger weight loss in early trials but is not yet approved for weight loss — it is available as Mounjaro for type 2 diabetes.

Behavioral approaches — working with a dietitian, joining a structured weight-loss program, or using cognitive behavioral therapy — produce slower weight loss (typically 5 to 10 percent over a year) but do not require ongoing medication and do not have side effects. Many people combine behavioral approaches with medication for better results.

Bariatric surgery (gastric bypass, gastric sleeve) produces larger weight loss (30 to 50 percent) but carries surgical risks and permanent changes to digestion. It is typically reserved for people with severe obesity or obesity plus serious health conditions, and it requires lifelong dietary changes and vitamin supplementation.

Frequently Asked Questions

Does Wegovy work if you do not change your diet?

Wegovy reduces appetite, so you will likely eat less even without deliberate dieting. However, the clinical trials all included calorie reduction and exercise, so we do not have solid data on weight loss with Wegovy alone. In practice, people who use Wegovy without any dietary awareness tend to lose less weight than those who combine it with intentional eating changes.

Can you stay on Wegovy forever?

There is no known time limit. Some people use it long-term, the way they would use blood pressure medication. The longest trials ran about two years. If you and your doctor decide long-term use makes sense for your health, that is a reasonable choice — but you will need ongoing prescriptions, regular check-ins, and continued cost or insurance coverage.

What happens if you miss a dose?

Wegovy is injected once per week. If you miss a dose, inject it as soon as you remember, unless it is within two days of your next scheduled dose — in that case, skip the missed dose and resume your regular schedule. Missing one dose will not erase your progress, but missing multiple doses in a row may cause appetite to return and weight to start creeping back up.

Does Wegovy cause permanent changes to your metabolism?

No. Wegovy suppresses appetite while you take it, but it does not permanently alter how many calories you burn or how your body processes food. Once you stop, your metabolism returns to baseline. This is why weight regain is common after stopping — your body is not fundamentally different, just temporarily less hungry.

Is Wegovy the same as Ozempic?

They contain the same active ingredient (semaglutide) but at different doses. Ozempic is approved for type 2 diabetes at a lower dose. Wegovy is approved for weight loss at higher doses. Some doctors prescribe Ozempic off-label for weight loss because it is cheaper, but this is not an approved use and insurance is less likely to cover it.